Warning lights
Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.
-
Busy address KBO
22 other companies have their registered office at the same address; threshold 10.
Financials
Financial year 2025
FELIX PHARMA from Frameries, company number BE0477939091, closed financial year 2025 with a result of € 201 after tax. For that financial year FELIX PHARMA recorded a gross margin of € -350 and equity of € 560,583. Compared with financial year 2024, the result moved from € 382 to € 201. The company is profitable. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on June 30, 2026.
€ 560,583
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 201
▼ 47% vs 2024
Profit after tax over the fiscal year.
€ 170,354
Cash and bank balances on the last day of the fiscal year.
Stays in the company
No dividend for 2025. Retained profit grew to € 60,583.
Debts at end 2025
None
No bank loans on the last day of the fiscal year.
€ 400
Supplier invoices still open on the last day of the fiscal year.
| 2022 | 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|---|
| Gross margin | € -2,780 | € -721 | € -753 | € -350 | ▲ € 403 |
| Profit after taxes | € -3,004 | € -861 | € 382 | € 201 | ▼ 47% |
| Equity | € 560,860 | € 559,999 | € 560,382 | € 560,583 | |
| Total debts | € 0 | € 0 | € 0 | € 400 | |
| Cash | € 170,470 | € 169,609 | € 169,572 | € 170,354 | |
| Retained profit | € 60,860 | € 59,999 | € 60,382 | € 60,583 | |
| Balance sheet total | € 560,860 | € 559,999 | € 560,382 | € 560,983 |
Key figures of FELIX PHARMA, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.
What happened to FELIX PHARMA?
What happened at FELIX PHARMA in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- FINPHARMA stepped down as director. NBB
- GESTIPHARMA stepped down as director. NBB
- New annual accounts for financial year 2025: profit of € 201 (▼ 47% vs 2024). Source: NBB ↗
- FINPHARMA became a director. NBB
- GESTIPHARMA became a director. NBB
- New establishment in Mons. KBO
- Start of the company according to the CBE. KBO
In short
From € 3,004 loss in 2022 to € 201 profit in 2025.
Paid € 1,040 in corporate taxes since 2022.
Best year ever: 2024, with € 382 profit.
Management
Directors
According to the 2025 annual accounts
since 2022 · until 2028
Managing director · represented by PIERRE-PASCAL HECQ
Also active at: Les Pharmacies Réunies, Immobilière Général Léman, P.J. VLEUGELS et Cie, EVRAS, Les Pharmacies du Louvy, PHARMACIE CLAERHOUT, FARMIMMO, IMMOBILIERE SAINT GEORGES +12 more
since 2022 · until 2028
Establishments
Establishment units
Physical locations of this company
Rue Montavaux 155
7080 Frameries
Rue des Telliers **
7000 Mons
Active since 11 July 2003
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 22 companies are registered at this address.
All companies at this address →Les Pharmacies Réunies same network
€ 22,093 gross margin · 2025
Immobilière Général Léman same network
€ 92,019 gross margin · 2025
P.J. VLEUGELS et Cie same network
€ 132,509 gross margin · 2025
EVRAS same network
€ 47,127 gross margin · 2025
Pharmacie Grenez - Seeuws
€ 16,802 gross margin · 2025
+17 more
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 0477.939.091
- VAT number
- BE 0477.939.091
- Registered office
- Rue Montavaux 155, 7080 Frameries
- Names & denominations
- FELIX PHARMA
- Enterprise type
- Rechtspersoon
- Legal form
- Public limited company
- Legal situation
- Normale toestand
- Start date
- 9 July 2002
- Peppol
- Active · Active since 1 Jan 2001